May 7, 2010 – Findings from the SPIRIT IV trial, one of the largest randomized clinical trials comparing two drug eluting stents with 3,690 U.S.-based patients, were published this week in The New England Journal of Medicine.
May 6, 2010 – Patients who can postpone noncardiac surgery for at least six weeks after receiving a coronary stent are less likely to suffer reduced blood flow to the heart, heart attack and death than those who have surgery sooner. This was the finding of Scottish researchers in Circulation: Cardiovascular Interventions, an American Heart Association journal.
May 6, 2010 – After entered the Japanese drug-eluting stent market earlier this year, Abbott's Xience V and Boston Scientific's Promus stents picked up share from competitors Medtronic and Cordis, according to the market intelligence firm Millennium Research Group (MRG).
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
May 5, 2010 - Emergency department use of 256-slice computed tomography angiography (CTA) can help physicians triage patients with indeterminate chest pain without the need for additional diagnostic testing which can be costly and time consuming, according to a study to be presented at the American Roentgen Ray Society (ARRS) 2010 Annual Meeting in San Diego, Calif.
May 5, 2010 – A federal jury awarded more than $29.4 million in damages in a patent infringement lawsuit between two interventional cardiology access dressing manufacturers. Marine Polymer Technologies Inc. won its case against HemCon Medical Technologies Inc. April 29 .
May 5, 2010 – Catheter ablation of ventricular tachycardia (VT) is one of the fastest growing electrophysiology (EP) procedures, but requires the delivery of robust lesions for clinical success. Stereotaxis Inc. is starting a multicenter clinical study on VT treatment outcomes using its Niobe Magnetic Navigation System.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
May 5, 2010 – A new high-definition intravascular imaging system gained U.S. Food and Drug Administration (FDA) clearance today. LightLab Imaging Inc. said its C7-XR optical coherence tomography (OCT) imaging system and companion C7 Dragonfly OCT imaging catheter are now available on the U.S. market.
May 4, 2010 - Researchers have developed a computer-based system that can automatically track patient-specific radiation dose exposure on every patient that receives a computed tomography (CT) scan, according to a study to be presented at American Roentgen Ray Society (ARRS) 2010 Annual Meeting in San Diego.
April 27, 2010 — While repair of large abdominal aortic aneurysms (AAA's) is well accepted, randomized clinical trials have failed to demonstrate benefit for early surgical repair of small aneurysms over surveillance, according to researchers from New York-Presbyterian Hospital in New York.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
April 28, 2010 — The U.S. District Court in Minnesota this week declined to accept the plea agreement between Guidant and the U.S. Justice Department related to its failure to report adverse events from its implantable cardioverter defibrillators (ICDs) in 2005. Boston Scientific acquired Guidant after the incident.
May 4, 2010 — Including a coronary artery calcium score in a risk assessment for future heart disease events — such as heart attacks — provides a better estimate in some populations than a standard coronary risk factors assessment, according to research supported by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH).
May 4, 2010 — New research released this week in the Journal of the American College of Cardiology shows the value of implantable cardiac device diagnostics in identifying worsening heart failure.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
May 4, 2010 – The U.S. District Court in New Hampshire is being asked this week to review and reverse a jury verdict on patent litigation involving two companies with competing hemostasis management technology used in the cath lab.
May 4, 2010 - Currently, using conventional imaging modalities to distinguish between acute and chronic aortic dissection (AD) for surgical risk evaluation is not possible. However, in a recent study, researchers were able to use fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) to detect reparatory hypermetabolism in the lacerated aortic wall of acute AD.
May 4, 2010 – A deal has been struck to produce a generic version of Merck & Company’s Zetia (ezetimibe). In the United States, the cholesterol modifying agent has annual U.S. sales of about $1.4 billion, according to IMS Health data.